Patent · US Active

Mito-honokiol compounds and methods of synthesis and use thereof

US11897910B2 · kind B2 · utility

0Cited by
2References
19Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 16, 2020
Grant dateFeb 13, 2024
Priority date
Expiry dateDec 30, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K45/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides mito-honokiol or mito-magnolol compounds, pharmaceutical compositions thereof, and methods of using the mito-honokiol or mito-magnolol compounds in the treatment of cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.